Skip to main content

Table 4 Factors associated with PIMs and DDIs in elderly (> 70 years) multidose users in Norway in 2018

From: Potentially inappropriate prescribing to older patients receiving multidose drug dispensing

Study population

Potentially inappropriate medications (PIM)

Drug-drug interactions

(DDI)

 

Type Ba

Type Ca

 

n

n

(%)

OR

(95% CI)

n

(%)

OR

(95% CI)

n

(%)

n

(%)

Age 70–79

11,435

4072

(35.6)

1

(ref)

7227

(63.2)

1

(ref)

7171

(62.7)

493

(4.3)

Age 80–89

21,633

5449

(25.2)

0.61

(0.57–0.64)

13,000

(60.1)

0.90

(0.85–0.95)

12,935

(59.8)

543

(2.5)

Age 90+

12,525

2793

(22.3)

0.55

(0.52–0.59)

6785

(54.2)

0.76

(0.72–0.81)

6754

(53.9)

226

(1.8)

No. of drugs

45,593

NA

1.15b

(1.15–1-16)

NA

1.30b

(1.28–1.30)

NA

NA

Male

15,503

8814

(22.6)

1

(ref)

8354

(53.9)

1

(ref)

8294

(53.5)

420

(2.7)

Female

30,090

3505

(29.3)

1.50

(1.43–1.58)

18,658

(62.0)

1.43

(1.37–1.50)

18,566

(61.7)

842

(2.8)

  1. a: Type B = “Precautions should be taken”, Type C = “should be avoided”
  2. b: Increase in odds for PIMs and DDIs for every one unit increase in the number of drugs